SB-742457

DRUG4 trials

Sponsors

GlaxoSmithKline

Conditions

Alzheimer's Disease

Phase 1

A Study To Assess The Pharmacokinetics Of SB-742457 Formulated As A Capsule And A Tablet In Healthy Elderly Volunteers.

CompletedNCT00551772

GlaxoSmithKlineAlzheimer's Disease

Start: 2007-08-31Target: 12Updated: 2008-12-25

Phase 2

A Dose Ranging Study To Investigate The Efficacy And Safety Of SB-742457 In Alzheimer's Disease

CompletedNCT00224497

GlaxoSmithKlineAlzheimer's Disease

Start: 2005-09-30Target: 380Updated: 2009-12-24

SB-742457 And Donepezil In Alzheimer's Disease

CompletedNCT00348192

GlaxoSmithKlineAlzheimer's Disease

Start: 2006-05-31Target: 200Updated: 2009-06-02

Study of SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease

CompletedNCT00708552

GlaxoSmithKlineAlzheimer's Disease

Start: 2008-07-04End: 2010-03-09Updated: 2018-07-27

Related Papers

Two randomized controlled trials of SB742457 in mild‐to‐moderate Alzheimer's disease

Alzheimer s & Dementia Translational Research & Clinical Interventions2015-05-0645 citations